Brown/LUNGevity Award to Understand Mechanisms of Resistance to Immunotherapy
| קרן | LUNGevity |
|---|---|
| מדינה | U.S.A. |
| סוג | Research Grants |
| תאריך אחרון | 09/02/2024 |
| פקולטה | Life Sciences, Medicine |
| תיאור | The research funded through this award is expected to have a direct clinical impact on patients with NSCLC whose tumors have progressed on currently approved immunotherapy regimens. Through this RFA mechanism, LUNGevity is interested in answering these questions: • How do cells escape immunotherapy after an initial response, i.e., what is/are the mechanism(s) causing acquired resistance to immunotherapy? • What’s next for patients whose tumors have progressed after first-line immunotherapy regimens?
Funding: $500,000 total
Duration: 2 years
Research Authority due date: 1.2.24
LOI (required) due date: 9.2.24
Full proposal due date: 8.5.24
|
| קבצים מצורפים | |
| קישור | לאתר |
| עדכון אחרון | עדכון אחרון: 15/01/2024 |
